Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt
Transgene Detail
|
|
| Symbol: |
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt |
| Name: |
transgene insertion A, Astar Winoto |
| MGI ID: |
MGI:5661474 |
| Synonyms: |
BH3 Tg |
| Transgene: |
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt Location: unknown
|
| Alliance: |
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Homolog in Mouse |
Note |
| human |
BCL2 (596) |
|
Expresses human BCL2 with amino acids 101-103 mutated from glycine-aspartate-aspartate to alanine-alanine-alanine |
|
| |
|
Mutation details: The human BCL2 with amino acids 101-103 mutated from glycine-aspartate-aspartate to alanine-alanine-alanine to abolish BH3 domain pro-apoptotic function is under the control of the T cell-specific Cd4 locus control region (LCR). Immunohistochemistry confirmed expression of the transgene in thymocytes. A compensatory downregulation of endogenous mouse Bcl2 in the thymus, lymph nodes, and spleen is seen with transgene expression. Two lines were chosen for analysis, A and B, with similar phenotypes.
(J:217939)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:217939 Burger ML, et al., T cell-specific inhibition of multiple apoptotic pathways blocks negative selection and causes autoimmunity. Elife. 2014;3 |
| All: |
1 reference(s) |
|